Advances in the study of the role of high-frequency mutant subunits of the SWI/SNF complex in tumors
2024

The Role of High-Frequency Mutant Subunits of the SWI/SNF Complex in Tumors

publication Evidence: high

Author Information

Author(s): Zhao Jiumei, Zhu Jing, Tang Yu, Zheng Kepu, Li Ziwei

Primary Institution: Chongqing Nanchuan District People’s Hospital, Chongqing, China

Hypothesis

Mutations in the SWI/SNF complex subunits, particularly ARID1A and SMARCA4, may introduce vulnerabilities to various cancers.

Conclusion

The study highlights the significant role of ARID1A and SMARCA4 mutations in tumorigenesis and their potential as targets for precise cancer therapies.

Supporting Evidence

  • Approximately 25% of cancers have one or more SWI/SNF subunit genetic abnormalities.
  • ARID1A is the most commonly mutated subunit in the SWI/SNF complex and is associated with various cancers.
  • Mutations in ARID1A can lead to inactivation and absence of its protein expression, affecting tumor cell behavior.

Takeaway

Some parts of our cells that help control how genes work can get broken in cancer, and fixing these parts might help treat the disease better.

Methodology

The review summarizes existing research on the mechanisms of ARID1A and SMARCA4 in tumors and their implications for targeted therapy.

Limitations

The review does not provide new experimental data but synthesizes existing literature, which may not cover all recent findings.

Digital Object Identifier (DOI)

10.3389/fonc.2024.1463892

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication